🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the efficacy, safety, and tolerability of 16 or 24 w...
Status
Completed
Location
Multiple Locations
Start Date
2013-09-24
Trial ID
NCT01962441
The primary objective of this post-marketing surveillance study is to colle...
Status
Completed
Location
CHA Bundang Medical Center
Start Date
2016-12-05
Trial ID
NCT02951364
Treatments Being Tested
The primary objectives of this study are to evaluate the antiviral efficacy...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2020-01-03
Trial ID
NCT04211909
Treatments Being Tested
The primary objectives of this study are to determine the antiviral efficac...
Status
Completed
Location
Multiple Locations
Start Date
2015-12-22
Trial ID
NCT02613871
Treatments Being Tested
This study is to evaluate the safety, tolerability, and antiviral activity ...
Status
Completed
Location
Multiple Locations
Start Date
2012-10
Trial ID
NCT01713283
The primary objectives of this study are to evaluate the antiviral efficacy...
Status
Completed
Location
UCSD
Start Date
2013-04
Trial ID
NCT01858766
This is a randomized, multi-site, open-label trial of the co-administration...
Status
Completed
Location
Multiple Locations
Start Date
2016-01-05
Trial ID
NCT02601573
Treatments Being Tested
Background: Summary of Findings (SoF) tables have been developed to present...
Status
Completed
Location
Department of Health Research Methods, Evidence and Impact
Start Date
2018-01-08
Trial ID
NCT02813941
Treatments Being Tested
People who are infected with Hepatitis C Virus (HCV) have a great chance of...
Status
Terminated
Location
Ucsf Aids Crs (801)
Start Date
2016-02-17
Trial ID
NCT02605304
Treatments Being Tested
This study will evaluate ledipasvir/sofosbuvir (LDV/SOF) fixed-dose combina...
Status
Completed
Location
Multiple Locations
Start Date
2013-09
Trial ID
NCT01938430